functional dyenin-dynactin complex. These data support the interpretation that the labeling of Synaptobrevin-1::GFP largely occurs after vesicle fusion at the synapse which is subsequently transported to other regions of the neuron. This method can be readily adapted to any transmembrane protein on synaptic vesicles with a GFP tag inside the vesicle. We are currently testing this method on other transmembrane proteins with a GFP tag inside the vesicle. We intend to use this method to study if the synapse regulates retrograde transport and if retrograde transport of synaptic vesicle proteins is altered in pathological conditions such as axon injury. Many common and permanently disabling human birth defects, such as spina bifida, are caused by cell shape changes and tissue movements in early embryo. Therefore, it is important to understand how these cell changes are regulated during embryonic development. The actin cytoskeleton has been shown to be required for normal tissue movements at these stages. Furthermore, expression and localization of the cadherin-catenin complexes are relevant for cell adhesion and Factin assembly. The loss of cadherin-catenin complexes from the cell membrane can increase the risk of metastasis in carcinomas and alter normal cell movements during embryonic development. Using Xenopus laevis embryo as a model, we are currently investigating the mechanisms by which cortical actin assembly is regulated and the signaling pathways relevant for cadherin-catenin membrane localization. We have identified two G-couple protein receptors, a novel GPCR receptor termed xFlop and xLPA1 and the small GTPase Rac1 as key molecules involved in this process. We also showed that the phosphorylation status of alpha catenin is relevant to control C-cadherin membrane localization. We hope that this research could lead us not only to have a better understanding of cortical actin assembly and remodeling in early stages of Xenopus laevis embryos, but also to develop novel treatments for spina bifida and human cancer metastasis. doi:10.1016/j.ydbio.2010.05.345
Program/Abstract # 336 Arf6 recruits EPB41L5 for E-cadherin endocytosis during epithelial-mesenchyme transition Mariko Hirano, Shinichi Aizawa Lab. for BVertebrate Body Plan, CDB, RIKEN Kobe, Japan ADP-ribosylation factor6 (ARF6) has been suggested as a key modulator of E-cadherin degradation to disassemble the adherence junctions; Arf6 has been considered to regulate endosome traffic for the E-cadherin degradation. Here we propose another role of Arf6 in the initiation of E-cadherin destabilization by erythrocyte protein band4.1-like5 (EPB41L5), which we previously reported to be essential in epithelial-mesenchyme transition (EMT). BRAG2, a guanine-nucleotide exchange factor (GEF) of Arf6, associates with a-catenin. BRAG2 activates ARF6, and the activated ARF6 recruit EPB41L5 and ASAP1/2 from cytoplasm to plasma membrane to remove p120catenin from E-cadherin complex. Mesenchymal transition of NMuMG cells by TGFbeta is inhibited by either of BRAG2, Arf6 or ASAP1/2 siRNA. We would like to discuss about precise mechanisms as to how EPB41L5 mediates endocytosis of E-cadherin by virtue of Arf6, BRAG2 and ASAP1 during EMT. 
